NRXP
NRX TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
NRXP Profile
Nrx Therapeutics, Inc.
A clinical stage pharmaceutical company that develops novel therapies to treat central nervous system disorders
1201 Orange Street, Suite 600, Wilmington, Delaware 19801
--
NRX Therapeutics, Inc., was incorporated on May 20, 2015 under the laws of the State of Delaware. The Company is a clinical-stage biopharmaceutical company that, through its wholly-owned operating subsidiary, NeuroRx, Inc., develops and distributes novel therapies for the treatment of central nervous system diseases, including suicidal depression, chronic pain, post-traumatic stress disorder and now schizophrenia.
